Since 2020, the ISOLDA consortium has been collaborating to develop improved vaccines against viral infections for older adults. The collaboration has resulted in a number of peer-reviewed articles in academic...Read More
The EU Research and Innovation programme HORIZON 2020 has awarded a contract to the ISOLDA consortium, led by Stiftung Tieraerztliche Hochschule Hannover (TiHo), to develop improved vaccines against viral infections...Read More
The ISOLDA project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 848166.